Extramammary Paget’s disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies

Maeda, T., Kitamura, S., Nishihara, H. and Yanagi, T.  Extramammary Paget’s disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies.  Oncogene. 2020.  doi: 10.1038/s41388-020-01404-x

Date

BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.